These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32057682)

  • 21. MicroRNAs: novel diagnostic and therapeutic tools for pancreatic ductal adenocarcinoma?
    Mardin WA; Mees ST
    Ann Surg Oncol; 2009 Nov; 16(11):3183-9. PubMed ID: 19636633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The importance of quality-of-life management in patients with advanced pancreatic ductal adenocarcinoma.
    Lewis AR; Pihlak R; McNamara MG
    Curr Probl Cancer; 2018; 42(1):26-39. PubMed ID: 29631711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neoplasia and hyperplasia of pancreatic endocrine tissue in the rat: an immunocytochemical study.
    Spencer AJ; Andreu M; Greaves P
    Vet Pathol; 1986 Jan; 23(1):11-5. PubMed ID: 3004001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mixed ductal-endocrine carcinomas of the pancreas and ductal adenocarcinomas with scattered endocrine cells: characterization of the endocrine cells.
    Ohike N; Jürgensen A; Pipeleers-Marichal M; Klöppel G
    Virchows Arch; 2003 Mar; 442(3):258-65. PubMed ID: 12647216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The link between exocrine pancreatic cancer and the endocrine pancreas.
    Pour PM; Schmied B
    Int J Pancreatol; 1999 Apr; 25(2):77-87. PubMed ID: 10360219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-132 Plays an Independent Prognostic Role in Pancreatic Ductal Adenocarcinoma and Acts as a Tumor Suppressor.
    Chen Y; Zhu H; Wang Y; Song Y; Zhang P; Wang Z; Gao J; Li Z; Du Y
    Technol Cancer Res Treat; 2019 Jan; 18():1533033818824314. PubMed ID: 30803373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pancreatic Ductal Adenocarcinoma: The Dawn of the Era of Nuclear Medicine?
    Montemagno C; Cassim S; De Leiris N; Durivault J; Faraggi M; Pagès G
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gelatinases and inhibitors of gelatinases in pancreatic islets and islet cell tumors.
    Tomita T; Iwata K
    Mod Pathol; 1997 Jan; 10(1):47-54. PubMed ID: 9021726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On the role of the islets of Langerhans in pancreatic cancer.
    Hennig R; Ding XZ; Adrian TE
    Histol Histopathol; 2004 Jul; 19(3):999-1011. PubMed ID: 15168361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatic fatty degeneration and fibrosis as predisposing factors for the development of pancreatic ductal adenocarcinoma.
    Tomita Y; Azuma K; Nonaka Y; Kamada Y; Tomoeda M; Kishida M; Tanemura M; Miyoshi E
    Pancreas; 2014 Oct; 43(7):1032-41. PubMed ID: 24991971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malignant epithelial/exocrine tumors of the pancreas.
    Luchini C; Grillo F; Fassan M; Vanoli A; Capelli P; Paolino G; Ingravallo G; Renzulli G; Doglioni C; D'Amuri A; Mattiolo P; Pecori S; Parente P; Florena AM; Zamboni G; Scarpa A
    Pathologica; 2020 Sep; 112(3):210-226. PubMed ID: 33179623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pancreatic ductal adenocarcinoma and acinar cells: a matter of differentiation and development?
    Rooman I; Real FX
    Gut; 2012 Mar; 61(3):449-58. PubMed ID: 21730103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolving treatment options for locally advanced unresectable pancreatic ductal adenocarcinoma.
    Cinar P; Ko AH
    J Natl Compr Canc Netw; 2014 Feb; 12(2):167-72. PubMed ID: 24586078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The epigenetic regulators Bmi1 and Ring1B are differentially regulated in pancreatitis and pancreatic ductal adenocarcinoma.
    Martínez-Romero C; Rooman I; Skoudy A; Guerra C; Molero X; González A; Iglesias M; Lobato T; Bosch A; Barbacid M; Real FX; Hernández-Muñoz I
    J Pathol; 2009 Oct; 219(2):205-13. PubMed ID: 19585519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health Disparities Impact Expected Treatment of Pancreatic Ductal Adenocarcinoma Nationally.
    Lutfi W; Zenati MS; Zureikat AH; Zeh HJ; Hogg ME
    Ann Surg Oncol; 2018 Jul; 25(7):1860-1867. PubMed ID: 29691733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesoscopic 3D imaging of pancreatic cancer and Langerhans islets based on tissue autofluorescence.
    Hahn M; Nord C; Franklin O; Alanentalo T; Mettävainio MI; Morini F; Eriksson M; Korsgren O; Sund M; Ahlgren U
    Sci Rep; 2020 Oct; 10(1):18246. PubMed ID: 33106532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Supportive care in pancreatic ductal adenocarcinoma.
    Laquente B; Calsina-Berna A; Carmona-Bayonas A; Jiménez-Fonseca P; Peiró I; Carrato A
    Clin Transl Oncol; 2017 Nov; 19(11):1293-1302. PubMed ID: 28612201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro influences between pancreatic adenocarcinoma cells and pancreatic islets.
    Wang F; Larsson J; Adrian TE; Gasslander T; Permert J
    J Surg Res; 1998 Sep; 79(1):13-9. PubMed ID: 9735234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trefoil factor family peptides in normal and diseased human pancreas.
    Guppy NJ; El-Bahrawy ME; Kocher HM; Fritsch K; Qureshi YA; Poulsom R; Jeffery RE; Wright NA; Otto WR; Alison MR
    Pancreas; 2012 Aug; 41(6):888-96. PubMed ID: 22286382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exocrine-endocrine pancreatic cancer and alpha-fetoprotein.
    Brandi G; Nobili E; Capizzi E; Corti B; Di Cicilia R; Di Marco M; Biasco G
    Pancreas; 2008 Aug; 37(2):223-5. PubMed ID: 18665089
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.